首页> 美国卫生研究院文献>Advances in Hematology >Assessing the Performance of Extended Half-Life Coagulation Factor VIII FC Fusion Protein by Using Chromogenic and One-Stage Assays in Saudi Hemophilia A Patients

【2h】

Assessing the Performance of Extended Half-Life Coagulation Factor VIII FC Fusion Protein by Using Chromogenic and One-Stage Assays in Saudi Hemophilia A Patients

机译：通过在沙特血友病中使用发色性和一阶段测定来评估延长半衰期凝固因子VIIIFc融合蛋白的性能

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

期刊名称 Advances in Hematology
作者
Tarek M. Owaidah; Hazzaa A. Alzahrani; Nouf S. Al-Numair; Abdulmjeed O. Alnosair; Amelita M. Aguilos; Mahasen Saleh;
展开▼
作者单位

展开▼
年(卷),期 2020(-1),-1
年度 2020
页码 -1
总页数 7
原文格式 PDF
正文语种
中图分类血液学检验;
关键词

相似文献

外文文献
中文文献
专利

1. Assessing the Performance of Extended Half-Life Coagulation Factor VIII, FC Fusion Protein by Using Chromogenic and One-Stage Assays in Saudi Hemophilia A Patients [J] . Tarek M. Owaidah, Hazzaa A. Alzahrani, Nouf S. Al-Numair, Advances in hematology . 2020,第3期

机译：通过在沙特血友病中使用发色性和一阶段测定来评估延长半衰期凝固因子VIII，Fc融合蛋白的性能
2. Discrepancies between the one-stage clotting assay and chromogenic assay in patients with hemophilia A receiving standard or extended half-life factor VIII products in clinical settings [J] . Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis . 2020,第期

机译：血友病患者的单阶段凝血测定和发色测定之间的差异在临床环境中接受标准或延长半衰期VIII产品的患者
3. Discrepancy between the results of one-stage and chromogenic factor VIII:C assays in patients with mild/moderate hemophilia A [J] . Vosough Fatemeh, Ahmadinejad Minoo, Toogeh Gholamreza, Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis . 2020,第8期

机译：一种阶段和发色因子VIII的结果之间的差异：轻度/中度血友病患者的C测定
4. Inactiwatlon of Animal Factor VIII by human Factor VIII Inhibitors: Inwestigation of Plasma from Patients with Inhibitors in congenital Hemophilia I and from Patients with acquired Hemophilia A [C] . V. Aumann, G. Lutze (Jr.), G. Lutze (Sen.), Hemophilie-Symposion . 2003

机译：人为因子VIII抑制剂的动物因子VIII的乙酰丁酮：先天性血友病药中抑制剂患者的血浆中的预防
5. Immunity and tolerance to coagulation co-factor VIII in the treatment of hemophilia A. [D] . Skupsky, Jonathan. 2009

机译：血友病A治疗中对凝血因子VIII的免疫力和耐受性。
6. Half-life–extended recombinant coagulation factor IX–albumin fusion protein is recycled via the FcRn-mediated pathway [O] . Jenny Chia, Jade Louber, Isabelle Glauser, 2018

机译：半衰期延长的重组凝血因子IX-白蛋白融合蛋白通过FcRn介导的途径回收
7. Assessing the Performance of Extended Half-Life Coagulation Factor VIII, FC Fusion Protein by Using Chromogenic and One-Stage Assays in Saudi Hemophilia A Patients [O] . Tarek M. Owaidah, Hazzaa A. Alzahrani, Nouf S. Al-Numair, 2020

机译：通过在沙特血友病中使用发色性和一阶段测定来评估延长半衰期凝固因子VIII，Fc融合蛋白的性能

Assessing the Performance of Extended Half-Life Coagulation Factor VIII FC Fusion Protein by Using Chromogenic and One-Stage Assays in Saudi Hemophilia A Patients

著录项

引文网络

相似文献

相关主题

期刊订阅